DIN 02562502 — APO-DASATINIB TABLETS 100 MG
APO-DASATINIB TABLETS is a tablet of Dasatinib marketed by APOTEX INC. The full Dasatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02562502
- Brand name
- APO-DASATINIB TABLETS
- Active ingredient
- Dasatinib
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (BCR-ABL tyrosine kinase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dasatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02470721 | APO-DASATINIB | 100 MG | TABLET | APOTEX INC | MARKETED |
| 02470705 | APO-DASATINIB | 20 MG | TABLET | APOTEX INC | MARKETED |
| 02470713 | APO-DASATINIB | 50 MG | TABLET | APOTEX INC | MARKETED |
| 02481499 | APO-DASATINIB | 70 MG | TABLET | APOTEX INC | MARKETED |
| 02481502 | APO-DASATINIB | 80 MG | TABLET | APOTEX INC | MARKETED |
| 02562464 | APO-DASATINIB TABLETS | 20 MG | TABLET | APOTEX INC | MARKETED |
| 02562472 | APO-DASATINIB TABLETS | 50 MG | TABLET | APOTEX INC | MARKETED |
| 02562480 | APO-DASATINIB TABLETS | 70 MG | TABLET | APOTEX INC | MARKETED |
| 02562499 | APO-DASATINIB TABLETS | 80 MG | TABLET | APOTEX INC | MARKETED |
| 02514788 | REDDY-DASATINIB | 100 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02514796 | REDDY-DASATINIB | 140 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02514737 | REDDY-DASATINIB | 20 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02514745 | REDDY-DASATINIB | 50 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02514753 | REDDY-DASATINIB | 70 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02514761 | REDDY-DASATINIB | 80 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02320193 | SPRYCEL | 100 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02360829 | SPRYCEL | 140 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02293129 | SPRYCEL | 20 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02293137 | SPRYCEL | 50 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02293145 | SPRYCEL | 70 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02360810 | SPRYCEL | 80 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02499339 | TARO-DASATINIB | 100 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02499347 | TARO-DASATINIB | 140 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02499282 | TARO-DASATINIB | 20 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02499304 | TARO-DASATINIB | 50 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02499312 | TARO-DASATINIB | 70 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02499320 | TARO-DASATINIB | 80 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02478358 | TEVA-DASATINIB | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02478307 | TEVA-DASATINIB | 20 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02478315 | TEVA-DASATINIB | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02478323 | TEVA-DASATINIB | 70 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02478331 | TEVA-DASATINIB | 80 MG | TABLET | TEVA CANADA LIMITED | MARKETED |